Format

Send to

Choose Destination
See comment in PubMed Commons below
Horm Res. 2002;58 Suppl 3:27-9.

US experience in evaluation and diagnosis of GH therapy of intrauterine growth retardation/small-for-gestational-age children.

Author information

  • 1Department of Pediatrics, Division of Pediatric Endocrinology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY 10467, USA. phsaenger@aol.com

Abstract

The potential role of exogenous GH in treating short children born small for gestational age (SGA) has been discussed since the early 1960s. Pivotal studies in Europe during the last 10 years have shown that GH treatment of short children born SGA during childhood and early puberty (1) normalizes stature, (2) increases final height above predicted height and (3) allows children to reach their target height. A study now under way in the USA will provide additional much needed data about efficacy and safety of GH treatment in intrauterine growth retardation/SGA.

Copyright 2002 S. Karger AG, Basel

PMID:
12435893
DOI:
66479
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk